Highlights
NASDAQ: UTHR       United Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
128.97   -1.28 (0.98%)  128.44 - 130.865  43,174

Overview

 
Avg Volume (4 weeks):512,170
4 Weeks Range:101.09 - 133.67
4 Weeks Price Volatility (%):
85.57%
52 Weeks Range:75.58 - 133.67
52 Weeks Price Volatility (%):
91.91%
Average Price Target: 147.00
Price Target Upside/Downside: +18.03

Headlines



No recent Headlines for this stock.


Business Background

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. The Company markets and sells four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution (Tyvaso); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). The Company markets and sells an oncology product in the United States, Unituxin (dinutuximab) Injection (Unituxin), which is approved for treatment of neuroblastoma. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3122  2460  664  3150 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 HTZ 1.780.00 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 BLRX 2.19+0.71 
 XOG 0.271-0.062 
 TMUSR 0.121+0.031 
 AAPL 109.93-5.39 
 NIO 30.39-1.60 
 STI 70.13+0.87